LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY AS CONDITIONING REGIMENT FOLLOW BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR THE TREATMENT OF ADVANCED AML/MDS PATIENTS

被引：0
|
作者：
Shi, X. [1 ]
Ge, L. [1 ]
Sun, A. [1 ]
Zhu, X. [1 ]
Qiu, H. [1 ]
Jin, Z. [1 ]
Miao, M. [1 ]
Fu, C. [1 ]
Ma, X. [1 ]
Chen, F. [1 ]
Xue, S. [1 ]
Han, Y. [1 ]
Xue, M. [1 ]
Tang, X. [1 ]
Wu, D. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P355
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [31] DARTS, Bites and ADCs for the Treatment of AML and for Conditioning for Allogeneic Stem Cell Transplantation
    DiPersio, John F.
    Rettig, Mike
    Persaud, Steve
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S86 - S86
  • [32] Low-dose azacitidine for relapse of MDS/AML after unrelated donor peripheral blood stem cell transplantation
    Rossetti, James M.
    Shadduck, Richard K.
    Thatikonda, Chandana
    Sahovic, Entezam
    Lister, John
    BLOOD, 2007, 110 (11) : 338B - 338B
  • [33] Allogeneic stem cell transplantation in AML and MDS - Reduced conditioning for increased risk? The Munich/AMLCG approach
    Schmid, C.
    Schleuning, M.
    Kolb, H. -J.
    ANNALS OF HEMATOLOGY, 2006, 85 : 101 - 104
  • [34] Treosulfan/fludarabine as dose-reduced conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with AML and MDS/sAML
    Kröger, N
    Zabelina, T
    Schieder, H
    Kratochwille, K
    Ayuk, F
    Stute, N
    Fehse, N
    Hassenpflug, J
    Panse, J
    Casper, J
    Freund, M
    Zander, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S256 - S256
  • [35] Reduced intensity conditioning (RIC) for allogeneic hematopoietic stem cell transplantation (HCT) in patients with AML evolved from MDS or therapy related AML
    O'Donnell, MR
    Roberto, R
    Stein, AS
    Palmer, J
    Slovak, M
    Nakamura, R
    Snyder, DS
    Chang, K
    Pullarkat, V
    Forman, SJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 41 - 41
  • [36] Allogeneic Stem-Cell Transplantation in AML and MDS Using Conditioning Regimens with Different Dose-Intensities; 15 Years Later
    Shimoni, Avichai
    Shem-Tov, Noga
    Danylesko, Ivetta
    Yerushalmi, Ronit
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 147 - 148
  • [37] Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study
    Wang, Ling
    Wang, Li-ning
    Zhou, Ji-fang
    Gao, Wen-hui
    Jiang, Chuan-he
    Tang, Wei
    Zhao, Wei-li
    Hu, Jiong
    Jiang, Jie-ling
    FRONTIERS IN MEDICINE, 2021, 8
  • [38] Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study
    De Lima, Marcos
    Silva, Leandro de Padua
    Giralt, Sergio
    Komanduri, Krishna
    Andersson, Borje S.
    Hosing, Chitra
    Qazilbash, Muzaffar
    Shpall, Elizabeth
    Thall, Peter
    Zhang, Weiqing
    McCormick, Gloria
    Wang, Xuemei
    Popat, Uday
    Soriano, Andres
    Alousi, Amin
    Champlin, Richard
    Garcia-Manero, Guillermo
    BLOOD, 2008, 112 (11) : 414 - 414
  • [39] LOW-DOSE AZACITIDINE (AZA) AS MAINTENENCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM TRANSPLANTATION (HSCT) IN RELAPSED AML OR MDS: A NURSING PERSPECTIVE
    Metoyer, L. J.
    Caniplin, R.
    Gulbis, A.
    da Silva, L.
    de Lima, M.
    Giralt, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 150 - 150
  • [40] Dose-reduced conditioning with treosulfan/fludarabine followed by allogeneic stem cell transplantation from related and unrelated donors in patients with AML and MDS/sAML.
    Kroger, N
    Zabelina, T
    Schieder, H
    Ayuk, F
    Stute, N
    Kratochwille, A
    Fehse, N
    Hassenpflug, J
    Panse, J
    Casper, J
    Freund, M
    Zander, A
    BLOOD, 2003, 102 (11) : 334B - 334B
12345